Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.

BACKGROUND: Adherence problems, interactions and higher rate of risk activities have been observed in HIV individuals using recreational drugs. Our aim was to describe recreational drug use in both HIV individuals and general population in Europe, and to assess at what extent HIV guidelines address...

Descripción completa

Detalles Bibliográficos
Autores: Garin, Noe, Velasco Muñoz, César, Pourcq, Jan T. de, Lopez, Belen, Gutiérrez, Maria del Mar, Haro Abad, Josep Maria, Feliu, Anna, Mangues i Bafalluy, Ma. Antònia, Trilla García, Antoni
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/105676
Acceso en línea:https://hdl.handle.net/2445/105676
Access Level:acceso abierto
Palabra clave:VIH (Virus)
Persones seropositives
Europa
Drogues
HIV (Viruses)
HIV-positive persons
Europe
Drugs of abuse
id ES_3f70df182da0a02f1ad7eb6d29f0d2b7
oai_identifier_str oai:recercat.cat:2445/105676
network_acronym_str ES
network_name_str España
repository_id_str
spelling Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.Garin, NoeVelasco Muñoz, CésarPourcq, Jan T. deLopez, BelenGutiérrez, Maria del MarHaro Abad, Josep MariaFeliu, AnnaMangues i Bafalluy, Ma. AntòniaTrilla García, AntoniVIH (Virus)Persones seropositivesEuropaDroguesHIV (Viruses)HIV-positive personsEuropeDrugs of abuseBACKGROUND: Adherence problems, interactions and higher rate of risk activities have been observed in HIV individuals using recreational drugs. Our aim was to describe recreational drug use in both HIV individuals and general population in Europe, and to assess at what extent HIV guidelines address this issue. METHODS: Data on recreational drug use across Europe were obtained from the European Monitoring Centre for Drugs and Drug Addiction for the general population, and through Pubmed search. for HIV patients. We assessed the incorporation of recreational drug issues in HIV treatment guidelines for the following topics: (a) recreational drugs; (b) adherence to antiretrovirals; (c) interactions; (d) transmission risk. Guidelines included: World Health Organization; European Aids Clinical Society; U.S. Department of Health and Human Services; International Antiviral Society-USA; and seven European national guidelines. RESULTS: 29 countries reported recreational drug use in general population. The highest prevalences were observed for Cannabis (i.e., 8-10% in Spain, France, and Czech Republic) followed by cocaine, amphetamines and ecstasy. The 13 studies selected in the systematic review showed a great variability in recreational drug use on the HIV population. Apart from classical recreational drugs, we found a relevant use of new drugs including sexual experience enhancers. Polydrug consumption was about 50% in some studies. Most guidelines included general information about recreational drugs, showing great variability on the inclusion of the evaluated topics. We found more specific, evidence-based recommendations on interactions, followed by medication adherence and transmission risk. CONCLUSIONS: Available data on the people living with HIV suggest a higher use of recreational drugs than in the general population, which is already relevant. However, recreational drug issues should be included or addressed more thoroughly in most guidelines.Frontiers Media2017201720152017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion10 p.application/pdfhttps://hdl.handle.net/2445/105676Articles publicats en revistes (Medicina)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.3389/fmicb.2015.00690 (Corrigendum https://doi.org/10.3389/fmicb.2015.01229)Frontiers in Microbiology, 2015, vol. 6, num. 690https://doi.org/10.3389/fmicb.2015.00690cc-by (c) Garin, Noe et al., 2015http://creativecommons.org/licenses/by/3.0/esinfo:eu-repo/semantics/openAccessoai:recercat.cat:2445/1056762026-05-29T05:05:01Z
dc.title.none.fl_str_mv Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.
title Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.
spellingShingle Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.
Garin, Noe
VIH (Virus)
Persones seropositives
Europa
Drogues
HIV (Viruses)
HIV-positive persons
Europe
Drugs of abuse
title_short Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.
title_full Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.
title_fullStr Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.
title_full_unstemmed Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.
title_sort Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.
dc.creator.none.fl_str_mv Garin, Noe
Velasco Muñoz, César
Pourcq, Jan T. de
Lopez, Belen
Gutiérrez, Maria del Mar
Haro Abad, Josep Maria
Feliu, Anna
Mangues i Bafalluy, Ma. Antònia
Trilla García, Antoni
author Garin, Noe
author_facet Garin, Noe
Velasco Muñoz, César
Pourcq, Jan T. de
Lopez, Belen
Gutiérrez, Maria del Mar
Haro Abad, Josep Maria
Feliu, Anna
Mangues i Bafalluy, Ma. Antònia
Trilla García, Antoni
author_role author
author2 Velasco Muñoz, César
Pourcq, Jan T. de
Lopez, Belen
Gutiérrez, Maria del Mar
Haro Abad, Josep Maria
Feliu, Anna
Mangues i Bafalluy, Ma. Antònia
Trilla García, Antoni
author2_role author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv VIH (Virus)
Persones seropositives
Europa
Drogues
HIV (Viruses)
HIV-positive persons
Europe
Drugs of abuse
topic VIH (Virus)
Persones seropositives
Europa
Drogues
HIV (Viruses)
HIV-positive persons
Europe
Drugs of abuse
description BACKGROUND: Adherence problems, interactions and higher rate of risk activities have been observed in HIV individuals using recreational drugs. Our aim was to describe recreational drug use in both HIV individuals and general population in Europe, and to assess at what extent HIV guidelines address this issue. METHODS: Data on recreational drug use across Europe were obtained from the European Monitoring Centre for Drugs and Drug Addiction for the general population, and through Pubmed search. for HIV patients. We assessed the incorporation of recreational drug issues in HIV treatment guidelines for the following topics: (a) recreational drugs; (b) adherence to antiretrovirals; (c) interactions; (d) transmission risk. Guidelines included: World Health Organization; European Aids Clinical Society; U.S. Department of Health and Human Services; International Antiviral Society-USA; and seven European national guidelines. RESULTS: 29 countries reported recreational drug use in general population. The highest prevalences were observed for Cannabis (i.e., 8-10% in Spain, France, and Czech Republic) followed by cocaine, amphetamines and ecstasy. The 13 studies selected in the systematic review showed a great variability in recreational drug use on the HIV population. Apart from classical recreational drugs, we found a relevant use of new drugs including sexual experience enhancers. Polydrug consumption was about 50% in some studies. Most guidelines included general information about recreational drugs, showing great variability on the inclusion of the evaluated topics. We found more specific, evidence-based recommendations on interactions, followed by medication adherence and transmission risk. CONCLUSIONS: Available data on the people living with HIV suggest a higher use of recreational drugs than in the general population, which is already relevant. However, recreational drug issues should be included or addressed more thoroughly in most guidelines.
publishDate 2015
dc.date.none.fl_str_mv 2015
2017
2017
2017
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/105676
url https://hdl.handle.net/2445/105676
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.3389/fmicb.2015.00690 (Corrigendum https://doi.org/10.3389/fmicb.2015.01229)
Frontiers in Microbiology, 2015, vol. 6, num. 690
https://doi.org/10.3389/fmicb.2015.00690
dc.rights.none.fl_str_mv cc-by (c) Garin, Noe et al., 2015
http://creativecommons.org/licenses/by/3.0/es
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Garin, Noe et al., 2015
http://creativecommons.org/licenses/by/3.0/es
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 10 p.
application/pdf
dc.publisher.none.fl_str_mv Frontiers Media
publisher.none.fl_str_mv Frontiers Media
dc.source.none.fl_str_mv Articles publicats en revistes (Medicina)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869406633253142528
score 15,811543

Similares en LA Referencia